EXPERT PERSPECTIVES IN VITILIGO

Experts in the field discuss new therapies and how they will impact a dermatology practice.

Raj Chovatiya, MD, PhD: Utilizing Ruxolitinib Cream for Patients with Vitiligo

Dr. Chovatiya discusses how to effectively treat patients with vitiligo using topical ruxolitinib cream. He emphasizes the importance of a slow and steady treatment regimen that targets stopping inflammation and stimulating repigmentation.

MORE EXPERT PERSPECTIVES IN VITILIGO

Dr. Del Rosso, JCAD’s Clinical Editor-in-Chief, reviews a poster presented by Volkova et al at the 2024 American Academy of Dermatology annual meeting. The poster presented findings from the TRuE-V long-term extension (LTE) study, which evaluated changes in serum biomarkers in patients with segmental vitiligo who were randomized in the LTE to apply the vehicle or continue using ruxolitinib 1.5% cream after both groups had used ruxolitinib cream in the parent studies....
Dr. Elbuluk discusses a recently published retrospective chart review that she and her colleagues published in the Archives of Dermatological Research, which included all patients diagnosed with vitiligo treated at a private hospital and a public hospital over a period of ten years, with a focus on associated psychiatric comorbidities. She summarizes the findings of rates of anxiety and depression in patients with vitiligo in terms of gender, race, and socioeconomic status....